KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Change in Acquisitions & Divestments (2022 - 2025)

Biolife Solutions (BLFS) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 256.22% to $3.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.8 million, a 94.12% increase, with the full-year FY2025 number at $6.8 million, up 94.12% from a year prior.
  • Change in Acquisitions & Divestments was $3.2 million for Q4 2025 at Biolife Solutions, up from $1.8 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $3.2 million in Q4 2025 to a low of -$330000.0 in Q4 2022.
  • A 4-year average of $1.0 million and a median of $909000.0 in 2024 define the central range for Change in Acquisitions & Divestments.
  • Biggest YoY gain for Change in Acquisitions & Divestments was 256.22% in 2025; the steepest drop was 41.11% in 2025.
  • Biolife Solutions' Change in Acquisitions & Divestments stood at -$330000.0 in 2022, then skyrocketed by 250.91% to $498000.0 in 2023, then surged by 82.53% to $909000.0 in 2024, then surged by 256.22% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Change in Acquisitions & Divestments are $3.2 million (Q4 2025), $1.8 million (Q3 2025), and $1.2 million (Q2 2025).